Applied DNA Sciences (NASDAQ:APDN – Get Free Report) released its earnings results on Tuesday. The technology company reported ($0.32) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.01, Zacks reports. Applied DNA Sciences had a negative return on equity of 138.41% and a negative net margin of 214.42%.
Applied DNA Sciences Price Performance
Shares of Applied DNA Sciences stock opened at $0.23 on Thursday. The stock has a market capitalization of $11.93 million, a P/E ratio of -0.02 and a beta of 0.46. Applied DNA Sciences has a one year low of $0.12 and a one year high of $14.40. The business’s 50 day simple moving average is $0.22 and its two-hundred day simple moving average is $0.60.
Wall Street Analyst Weigh In
Separately, StockNews.com raised Applied DNA Sciences to a “sell” rating in a report on Tuesday, September 17th.
About Applied DNA Sciences
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Further Reading
- Five stocks we like better than Applied DNA Sciences
- Pros And Cons Of Monthly Dividend Stocks
- Stock Buybacks Outperform Dividends: Here’s the Key Advantage
- What is the S&P 500 and How It is Distinct from Other Indexes
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- 5 Top Rated Dividend Stocks to Consider
- Why Now Is the Ultimate Time to Invest in Oil Stocks
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
